Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Large Cap
  • Legal
  • Markets
  • Media
  • News
  • Politics

Fox News’ Legal Hurdles: Confidential Settlement in Defamation Case Precedes Upcoming Dominion Trial

By Lekha Gupta
April 10, 10:14 AM
Fox News, a unit of Fox Corporation (NASDAQ: FOXA), and one of its former hosts disclosed the settlement of a defamation lawsuit with Venezuelan businessman Majed Khalil.

FOX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer

By Vandana Singh
April 10, 7:18 AM
Merck & Co Inc (NYSE:MRK) and Eisai Co Ltd (OTC:ESALY) are discontinuing the Phase 3 LEAP-003 trial evaluating Keytruda plus Lenvima…

ESALF

Read More
1 minute read
  • Commodities
  • Large Cap
  • M&A
  • Markets
  • Media
  • Mid Cap
  • News
  • Rumors
  • Top Stories
  • Trading Ideas

ExxonMobil Explores Acquisition Of Pioneer Natural Amid Bid To Dominate Permian Basin

By AJ Fabino
April 7, 4:32 PM
Exxon Mobil Corp. (NYSE: XOM) is reportedly in early stage discussions with Pioneer Natural Resources Co. (NYSE: PXD) about a potential acquisition, the Wall Street Journal

OXY

Read More
2 minute read
  • Entertainment
  • General
  • Large Cap
  • News
  • Tech
  • Top Stories

Was Steve Jobs A Genius Or Jerk? Retired Apple Engineer Tells The Tale

By AJ Fabino
April 7, 4:24 PM
As one of the most innovative and successful businessmen in history, Apple Inc (NASDAQ: AAPL) founder Steve Jobs has been both revered and reviled for his actions and decisions.

AAPL

Read More
2 minute read
  • General
  • Large Cap
  • News
  • Restaurants
  • Top Stories

Not Lovin’ It: McDonald’s Cuts Pay, Slashes Corporate Titles In Latest Restructuring Efforts

By AJ Fabino
April 7, 3:08 PM
Chicago-based McDonald's Corp. (NYSE: MCD) has triggered a sweeping restructuring plan that affects hundreds of employees worldwide, with some facing layoffs and others seeing cuts to their compensation packages.

MCD

Read More
1 minute read
  • Large Cap
  • Markets
  • News
  • Press Releases

Powering Europe’s Future: Ford Debuts Commercial EV Compact Van for Continental Market

By Lekha Gupta
April 6, 3:00 PM
On Thursday, Ford Motor Co. (NYSE:F) launched a new all-electric commercial vehicle, E-Transit Courier, and expanded its line-up of innovative…

F

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Large Cap
  • News
  • Price Target
  • Reiteration

Levi Strauss’ Strong Business Model To Drive Growth In 2023, Says Analyst

By Lekha Gupta
April 6, 1:18 PM
Telsey Advisory Group analyst Dana Telsey reiterated an Outperform rating on Levi Strauss & Co (NYSE:LEVI) and a price target of $24 following…

LEVI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Global
  • Large Cap
  • Mid Cap
  • News
  • Price Target
  • Trading Ideas

Breaking Down The Bullish Case For General Electric: Analyst Calls For 36% Upside Potential

By AJ Fabino
April 6, 12:27 PM
General Electric Company (NYSE: GE), the multinational conglomerate that operates in various high-tech industrial capacities, is showing promising signs of growth, says Benzinga’s Gianni Di Poce.

GCTAF

Read More
4 minute read
  • Biotech
  • Econ #s
  • Economics
  • General
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • Markets
  • Media
  • News
  • Small Cap
  • Tech
  • Top Stories

Weekly Jobless Claims Higher Than Expected, US Big Techs Face Difficulty Downsizing In Europe, Biden Admin Finalizes Rule To Crack Down Deceptive Medicare Advantage Advertising: Today’s Top Stories

By Vandana Singh
April 6, 9:45 AM
Benzinga Weekly Jobless Claims Fall 18K To 228K, Still Higher Than Expected

AMZN

Read More
1 minute read
  • General
  • Large Cap
  • News

Boeing Restarts Delivering 767 Freighters After Hiatus Of Three Months

By Vandana Singh
April 6, 8:23 AM
Boeing Co (NYSE: BA) has reportedly restarted deliveries of its widebody 767 after a three-month pause caused by supplier quality issues.

BA

Posts pagination

Previous 1 … 338 339 340 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service